As of November 2025, according to Cintas's current financial statements, the company's 12-month EPS is $4.57. For the year 2025, the company recorded an earnings per share (EPS) of $4.48, which marks an increase compared to its EPS of $3.85 in 2024. Cintas's earnings per share for the quarterly report ending on Aug 31, 2025 reached $1.21.
The annual EPS for the year 2025 was $4.48, an increase of 16.4% from $3.85 in 2024. For the fiscal quarter that ended on Aug 31, 2025, the per-share earnings was $1.21, showing a 8% increase from the same quarter last year. For the twelve months ending August 2025, the EPS is $4.57. For the year 2024, the yearly earnings per share was $3.85, marking an increase of 16.7% from 2023.
During the last 12 months, Cintas has seen an EPS growth of 8% (YoY, quarterly). Throughout the last three years, the company had an average EPS growth of 14.6% per year. During the last 5 years, the company had an average EPS growth rate of 16.5%. When measured over a ten-year period, CTAS's average EPS growth rate was 17.2%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| GNTX Gentex Corp | 13.26 | -3.8% | 5.4% | 1.2% |
| UNF Unifirst Corp | 18.22 | 2.7% | 13.4% | 2.2% |
| ABM Abm Industries Inc | 23.62 | -66.1% | -11.6% | -7.5% |
| ARMK Aramark | 27.5 | -61.4% | N/A | -11.3% |
| HCSG Healthcare Services Group Inc | 32.71 | 3.8% | -6% | -9.1% |
| CTAS Cintas Corp | 40.66 | 16.4% | 14.6% | 16.5% |
All data is based on quarterly TTM periods, unless otherwise specified.